SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-22-000025
Filing Date
2022-05-05
Accepted
2022-05-05 17:00:20
Documents
90
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20220331.htm   iXBRL 10-Q 1646854
2 EX-10.1 ex03312022101non-empdircom.htm EX-10.1 16117
3 EX-31.1 ex03312022311.htm EX-31.1 13026
4 EX-31.2 ex03312022312.htm EX-31.2 12484
5 EX-32.1 ex03312022321.htm EX-32.1 8865
6 EX-32.2 ex03312022322.htm EX-32.2 8935
12 GRAPHIC image_0.jpg GRAPHIC 14049
13 GRAPHIC tvtx-20220331_g1.gif GRAPHIC 580484
  Complete submission text file 0001438533-22-000025.txt   9467067

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20220331.xsd EX-101.SCH 53019
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20220331_cal.xml EX-101.CAL 89377
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20220331_def.xml EX-101.DEF 312306
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20220331_lab.xml EX-101.LAB 653235
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20220331_pre.xml EX-101.PRE 454974
84 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20220331_htm.xml XML 1219735
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 22897452
SIC: 2834 Pharmaceutical Preparations